Hall Laurie J Trustee Has $4.97 Million Stake in Danaher Co. (NYSE:DHR)

Hall Laurie J Trustee boosted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,669 shares of the conglomerate's stock after purchasing an additional 1,065 shares during the period. Danaher comprises about 1.6% of Hall Laurie J Trustee's portfolio, making the stock its 18th largest holding. Hall Laurie J Trustee's holdings in Danaher were worth $4,974,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Wedge Capital Management L L P NC raised its position in Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate's stock worth $342,000 after acquiring an additional 38 shares in the last quarter. Certified Advisory Corp raised its holdings in shares of Danaher by 4.5% in the 2nd quarter. Certified Advisory Corp now owns 926 shares of the conglomerate's stock valued at $231,000 after purchasing an additional 40 shares during the period. Meridian Financial Partners LLC grew its holdings in Danaher by 4.4% during the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate's stock worth $266,000 after purchasing an additional 40 shares during the period. Kovack Advisors Inc. increased its position in Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate's stock worth $346,000 after buying an additional 41 shares during the last quarter. Finally, Well Done LLC raised its stake in Danaher by 1.2% in the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate's stock valued at $987,000 after buying an additional 42 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently weighed in on DHR. Royal Bank of Canada decreased their target price on Danaher from $333.00 to $311.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Citigroup dropped their price objective on shares of Danaher from $305.00 to $285.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. KeyCorp lifted their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a report on Wednesday, October 23rd. StockNews.com cut shares of Danaher from a "buy" rating to a "hold" rating in a report on Saturday, December 14th. Finally, Raymond James decreased their target price on Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $286.80.

Danaher Price Performance

Shares of Danaher stock traded down $3.49 on Monday, reaching $238.41. 3,044,734 shares of the stock were exchanged, compared to its average volume of 2,640,177. The firm's 50 day moving average is $234.85 and its 200-day moving average is $253.51. The firm has a market cap of $172.20 billion, a PE ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a one year low of $222.53 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the business posted $2.02 EPS. The company's revenue was up 3.1% compared to the same quarter last year. As a group, analysts anticipate that Danaher Co. will post 7.49 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher's payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.